Qi Bian
Impact in
- Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Gout, Hyperuricemia, Uric Acid
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
- Immunology 10
- Galectins and Cancer Biology 2
- IL-33, ST2, and ILC Pathways 2
- Immune cells in cancer 2
- Psoriasis: Treatment and Pathogenesis 2
-
- Glycosylation and Glycoproteins Research 3
- Inflammasome and immune disorders 3
- Co-authors
- Xiaobin Mei (6 shared papers)Jiajun Fan (6 shared papers)Dianwen Ju (5 shared papers)Tao Ding (3 shared papers)Jingyun Luan (3 shared papers)Shaofei Wang (2 shared papers)Xuyao Zhang (2 shared papers)Yilan Shen (5 shared papers)
- Journals
- PLoS ONE (3 papers)Applied Microbiology and Biotechnology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Acta Pharmaceutica Sinica B (1 paper)The American Journal of Surgery (1 paper)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Qi Bian
24 papers receiving 691 citations
Peers
Comparison fields: 5 of 87
- Nephrology 187
- Clinical Biochemistry 41
- Immunology 105
- Cancer Research 66
- Molecular Biology 285
Countries citing papers authored by Qi Bian
This map shows the geographic impact of Qi Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Bian more than expected).
Fields of papers citing papers by Qi Bian
This network shows the impact of papers produced by Qi Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Bian. The network helps show where Qi Bian may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Bian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 167 | |
| 2 | 2017 | 86 | |
| 3 | 2021 | 64 | |
| 4 | 2016 | 61 | |
| 5 | 2015 | 60 | |
| 6 | 2020 | 46 | |
| 7 | 2015 | 43 | |
| 8 | 2015 | 32 | |
| 9 | 2020 | 29 | |
| 10 | 2015 | 24 | |
| 11 | 2015 | 21 | |
| 12 | 2023 | 17 | |
| 13 | 2012 | 14 | |
| 14 | 2022 | 10 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2012 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 3 | |
| 20 | [Clinical and pathological characteristics in patients with clinically presumed hypertensive nephrosclerosis]. | 2006 | 3 |
About Qi Bian
Qi Bian is a scholar working on Immunology, Molecular Biology, Nephrology, Cancer Research and Surgery, having authored 25 papers that have together received 699 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Glycosylation and Glycoproteins Research (3 papers), Inflammasome and immune disorders (3 papers), Galectins and Cancer Biology (2 papers), Chronic Kidney Disease and Diabetes (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune cells in cancer (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Nephrology (187 citations), Clinical Biochemistry (41 citations), Immunology (105 citations), Cancer Research (66 citations) and Molecular Biology (285 citations). Qi Bian has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Xiaobin Mei, Jiajun Fan, Dianwen Ju, Tao Ding, Jingyun Luan, Shaofei Wang, Xuyao Zhang, Yilan Shen, Wei Chen and Jan Novák. Their work appears in journals such as PLoS ONE, Applied Microbiology and Biotechnology, Biochemical and Biophysical Research Communications, Acta Pharmaceutica Sinica B and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.